Tumor-infiltrating immune cells (ICs) can induce vascular endothelial growth factors, interferons and other cytokines, which upregulate the PD-L1 expression [6,29], affecting various intracellular signaling pathways, transcriptional, and translational levels, and resulting in cancer progression and metastasis [30]. This evidence concerns the gene CD274 and neoplasm.